Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Resources Required for Semi-Automatic Volumetric Measurements in Metastatic Chordoma: Is Potentially Improved Tumor Burden Assessment Worth the Time Burden?
J Digit Imaging. 2016 Jun;29(3):357-64. doi: 10.1007/s10278-015-9846-9.
J Digit Imaging. 2016.
PMID: 26596767
Free PMC article.
Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST.
Fenerty KE, Folio LR, Patronas NJ, Marté JL, Gulley JL, Heery CR.
Fenerty KE, et al.
BMC Cancer. 2016 Aug 23;16(1):672. doi: 10.1186/s12885-016-2699-x.
BMC Cancer. 2016.
PMID: 27553491
Free PMC article.
Clinical Trial.
Item in Clipboard
Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition.
Fenerty KE, Padget M, Wolfson B, Gameiro SR, Su Z, Lee JH, Rabizadeh S, Soon-Shiong P, Hodge JW.
Fenerty KE, et al.
J Immunother Cancer. 2018 Nov 29;6(1):133. doi: 10.1186/s40425-018-0445-4.
J Immunother Cancer. 2018.
PMID: 30486888
Free PMC article.
Item in Clipboard
Correction to: Immunotherapy Utilizing the Combination of Natural Killer- and Antibody Dependent Cellular Cytotoxicity (ADCC)-Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition.
Fenerty KE, Padget M, Wolfson B, Gameiro SR, Su Z, Lee JH, Rabizadeh S, Soon-Shiong P, Hodge JW.
Fenerty KE, et al.
J Immunother Cancer. 2019 Sep 2;7(1):234. doi: 10.1186/s40425-019-0715-9.
J Immunother Cancer. 2019.
PMID: 31477176
Free PMC article.
Item in Clipboard
Homologous recombination deficiency and molecular subtype are associated with immunogenicity in ovarian cancer.
Fares CM, Fenerty KE, Chander C, Theisen MK, Konecny GE.
Fares CM, et al. Among authors: fenerty ke.
Biomark Med. 2022 Jul;16(10):771-782. doi: 10.2217/bmm-2022-0044. Epub 2022 Jun 1.
Biomark Med. 2022.
PMID: 35642517
Item in Clipboard
Cite
Cite